Table 1 Availability of malaria testing and anti-malarials, among all screened private sector outlets
From: Private sector role, readiness and performance for malaria case management in Uganda, 2015
Availability among all outlets | Private for-profit health facility | Pharmacy | Drug store | Total private sector |
|---|---|---|---|---|
N = 1023 % (CI) | N = 493 % (CI) | N = 1967 % (CI) | N = 3483 % (CI) | |
Anti-malarials | ||||
Any anti-malarial | 93.1 (90.4, 95.1) | 98.3 (96.4, 99.2) | 93.4 (91.3, 95.0) | 93.4 (91.8, 94.7) |
Any ACT | 80.3 (74.2, 85.3) | 97.9 (96.1, 98.9) | 80.4 (76.9, 83.5) | 80.7 (77.3, 83.6) |
Any QAACT | 69.5 (63.2, 75.1) | 94.8 (91.6, 96.8) | 72.3 (68.2, 76.0) | 72.0 (68.2, 75.4) |
SP | 48.5 (42.1, 54.8) | 82.5 (76.3, 87.3) | 45.9 (40.3, 51.7) | 47.1 (42.1, 52.1) |
Oral quinine | 65.9 (60.7, 70.8) | 94.1 (89.1, 96.8) | 75.0 (70.8, 78.9) | 73.2 (69.5, 76.6) |
Other non-artemisinin therapya | 9.1 (6.2, 13.2) | 53.5 (43.1, 63.6) | 10.5 (8.4, 13.1) | 10.8 (9.1, 12.8) |
Injectable quinine | 67.1 (60.2, 73.4) | 79.5 (70.1, 86.5) | 20.0 (16.5, 24.0) | 31.9 (28.5, 35.6) |
Non oral artemisinin monotherapy | 47.7 (42.2, 53.3) | 84.0 (77.0, 89.2) | 10.9 (8.2, 14.4) | 20.6 (17.5, 24.1) |
Malaria diagnostic testing | ||||
Any diagnostic | 70.6 (63.6, 76.7) | 51.4 (44.1, 58.6) | 20.9 (17.8, 24.4) | 32.9 (29.4, 36.5) |
RDT | 47.4 (41.4, 53.4) | 51.4 (44.1, 58.6) | 20.1 (17.1, 23.4) | 26.8 (23.9, 30.0) |
Microscopy | 42.0 (35.1, 49.1) | 0.6 (0.2, 1.4) | 1.2 (0.6, 2.3) | 10.6 (8.5, 13.2) |
Readiness for malaria case management (ACT and malaria testing) | ||||
Quality assured ACT and testing | 52.5 (46.2, 58.6) | 49.0 (41.9, 56.1) | 16.1 (13.6, 19.0) | 25.1 (22.2, 28.4) |